Table 3.

Between group differences in non-secluded patients

	Nr 1 favoured product			Top 3 favoured products
	Psychiatrist (n = 71)	Emergency physician (n = 37)	Fisher’s exact p	Psychiatrist (n = 71)	Emergency physician (n = 37)	Fisher’s exact p
Alprazolam LA	0 (0)	0 (0)	–	1 (1.4)	0 (0)	–
Alprazolam	1 (1.4)	1 (2.7)	1.000	4 (5.6)	3 (8.1)	0.689
Aripiprazole	3 (4.2)	0 (0)	0.55	7 (9.9)	0 (0)	0.093
Bromazepam	0 (0)	0 (0)	–	1 (1.4)	0 (0)	–
Clonazepam	0 (0)	0 (0)	–	0 (0)	1 (2.7)	–
Clorazepaat	2 (2.8)	2 (5.4)	0.605	9 (12.7)	7 (18.9)	0.404
Clotiapine	17 (23.9)	4 (10.8)	0.128	28 (39.4)	15 (40.5)	1.000
Diazepam	0 (0)	5 (13.5)	0.004	3 (4.2)	17 (45.9)	<0.001
Droperidol	5 (7.0)	2 (5.4)	1.000	17 (23.9)	11 (29.7)	0.644
Escitalopram	0 (0)	0 (0)	–	0 (0)	2 (5.4)	0.115
Haloperidol	3 (4.2)	4 (10.8)	0.228	6 (8.5)	14 (37.8)	<0.001
Lorazepam	14 (19.7)	9 (24.3)	0.625	43 (60.6)	15 (40.5)	0.067
Midazolam	0 (0)	2 (5.4)	0.115	0 (0)	6 (16.2)	0.001
Olanzapine	17 (23.9)	7 (18.9)	0.631	40 (56.3)	15 (40.5)	0.156
Paliperidone	0 (0)	0 (0)	–	1 (1.4)	0 (0)	–
Pipamperone	0 (0)	0 (0)	–	3 (4.2)	1 (2.7)	1.000
Prazepam	0 (0)	0 (0)	–	1 (1.4)	0 (0)	–
Promethiazine	0 (0)	0 (0)	–	0 (0)	1 (2.7)	–
Quetiapine	5 (7.0)	0 (0)	0.163	22 (31)	0 (0)	<0.001
Risperidone	2 (2.8)	0 (0)	0.545	6 (8.5)	1 (2.7)	0.418
Trazodone	0 (0)	0 (0)	–	1 (1.4)	0 (0)	–
Sodium Valproate	0 (0)	1 (2.7)	–	4 (5.6)	1 (2.7)	0.659
Zuclopenthixol	0 (0)	0 (0)	–	2 (2.8)	1 (2.7)	1.000
Zuclopenthixol LA	2 (2.8)	0 (0)	0.545	14 (19.7)	0 (0)	0.002

Fisher’s exact test was performed when one of the two groups had at least two counts (two-sided).